Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC

Những quyển sách tương tự

• Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
  Bằng: Yue, Jinnan, et al.
  Được phát hành: (2018)
• Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)
  Bằng: Zhao, Qingnan, et al.
  Được phát hành: (2015)
• EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
  Bằng: Zhu, Xuan, et al.
  Được phát hành: (2019)
• Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
  Bằng: Zhao, Qingnan, et al.
  Được phát hành: (2015)
• Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
  Bằng: Arasada, Rajeswara Rao, et al.
  Được phát hành: (2018)